As part of the White House Initiative on Women’s Health Research, the Advanced Research Projects Agency for Health has established the ARPA-H Sprint for Women’s Health, which commits $100 million towards transformative research and development in women’s health (The Cancer Letter, Nov 17, 2023).
Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care. Now, lower-cost versions known as biosimilars are gaining ground, and a study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests their growing use is associated with lower costs for both insurers and patients.
